Health Care & Life Sciences » Pharmaceuticals | Auris Medical Holding AG

Auris Medical Holding AG

Auris Medical Holding AG
Stock Exchange NASDAQ Stock Market
EPS
$21.8
Market Cap
$5.03 M
Shares Outstanding
2.35 M
Public Float
24.22 M

Profile

Address
Clarendon House
Hamilton HC HM 11
Bermuda
Employees -
Website http://www.aurismedical.com
Updated 07/08/2019
Auris Medical Holding AG engages in the provision of biopharmaceutical business. It focuses on the development of novel products for the treatment of inner ear disorders. It includes tinnitus, haring loss, and meniere's disease.

Financials

View All

Thomas Meyer
Chairman & Chief Executive Officer
Hernan Levett
CFO & Principal Accounting Officer